Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2005

View Archived Issues

17-DMAG induces cytostasis in testicular teratocarcinoma cells

Atorvastatin shows potential as a chemopreventive agent

ED-B targeted therapy L19-IL2 effective in pancreatic cancer model

In vivo and in vitro data on ZP-120 reported

Bristol-Myers Squibb profiles Q1 developments

NDA submitted for indiplon tablets

Santarus submits Zegerid chewable tablets NDA

Second clinical study completed for E-Matrix

Data demonstrates wound healing effects of TB4

Myogen and Novartis expand cardiac drug discovery collaboration

Discovery and antitumor efficacy of ABT-737, a Bcl-2 blocker

Antitumor and antiangiogenic effects of the class III/V tyrosine kinase inhibitor SU-11657 in mice

IC-486051: a novel PDE4 inhibitor for overactive bladder treatment

Novel PDE4 inhibitor/M3 antagonist evaluated in preclinical models of COPD

JPM7 induces strong and fast rabbit tracheal muscle relaxation

Uracyst launched in U.K.

New approval for Arixtra

Vivitrex NDA accepted for priority review

Long-term benefits of Cypher stents in patients with coronary artery disease

Zemplar capsules receive FDA approval

Promising alternative to injectable anthrax vaccine

Additional data on efficacy of exenatide in patients with type 2 diabetes

Role of interleukin-13 in the pathogenesis of eosinophilic esophagitis

Flavonoid derivative suppresses NF-kappaB activation in human colonic epithelial cells

Alnylam and U of Georgia to develop RNAi therapeutic for flu

In vivo data on kallikreins in ovarian cancer reported by Ibex

Ablynx and NRC to develop Nanobodies for CNS diseases

New urological agents reported

New treatment option for anxiety and depression claimed by Roche

Recent Kosan patents cover therapeutic agents for gastric motility disorders

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...